Last reviewed · How we verify
NCT07485192: ESWT-HSP
Comparison of the Efficacy of Extracorporeal Shock Wave Therapy and Suprascapular Nerve Block in Hemiplegic Shoulder Pain
NA trial testing Conventional therapy group in Hemiplegic Shoulder Pain in 67 participants. Completed in 1 January 2024.
1 January 2024
Quick facts
| Lead sponsor | Kars State Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 67 |
| Start date | 1 April 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Conventional therapy group
- suprascapular nerve block — full drug profile →
- Extracorporeal Shock Wave Therapy
Conditions studied
- Hemiplegic Shoulder Pain — all drugs for Hemiplegic Shoulder Pain →
Sponsor
Kars State Hospital
Who can join
Adults 45 to 70, any sex, with Hemiplegic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and suprascapular nerve block (SSNB) with conventional treatment for hemiplegic shoulder pain. A total of 67 patients aged 45-70 years, treated at the Department of Physical Therapy and Rehabilitation at Başakşehir Çam and Sakura City Hospital between April 1, 2023, and January 1, 2024, were randomly assigned to three groups. The first group (n=24) received conventional treatment, the second group (n=22) received conventional treatment plus one session of ultrasound-guided suprascapular nerve block, and the third group (n=21) received conventional treatment plus ESWT applied for 2 weeks, 4 days per week at 12 Hz and 2-3 bars. All groups were evaluated clinically and ultrasonographically before treatment, at 1 month, and at 3 months. Pain intensity was assessed using the visual analog scale, upper extremity motor function with the Fugl-Meyer Motor Scale, and supraspinatus muscle tear size via ultrasound.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07485192
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conventional therapy group
Trials testing the same drug.
- NCT07049692 — Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy · NA · not yet recruiting
- NCT07370389 — The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster · NA · recruiting
- NCT07378059 — The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster · NA · recruiting
- NCT07370402 — The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster · NA · recruiting
- NCT07183761 — A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects Wit · Phase 2 · not yet recruiting
Other recruiting trials for Hemiplegic Shoulder Pain
Currently open trials in the same condition.
- NCT07203222 — Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder · NA · recruiting
- NCT06473389 — Efficacy of Suprascapular Radiofrequency Ablation in Hemiplegic Shoulder Pain · NA · recruiting
Other Kars State Hospital trials
Trials by the same sponsor.
- NCT07436000 — AI-Generated Audiovisual Education and Osteoporosis Knowledge · NA · completed
- NCT04790071 — Dry Needling Treatment in Hemiplegic Shoulder Pain · NA · completed
- NCT04730934 — Effects of the COVID-19 Pandemic on Fibromyalgia Patients · completed
- NCT04789811 — Exercise and Dry Needling Treatment Combination in Nocturnal Calf Cramps · NA · unknown
- NCT04640558 — Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07485192 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kars State Hospital
- Last refreshed: 20 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07485192.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing